Free Trial

UiPath (PATH) Stock Forecast & Price Target

UiPath logo
$13.25 +0.51 (+4.00%)
(As of 12/20/2024 05:45 PM ET)

UiPath - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
16
Buy
2

Based on 19 Wall Street analysts who have issued ratings for UiPath in the last 12 months, the stock has a consensus rating of "Hold." Out of the 19 analysts, 1 has given a sell rating, 16 have given a hold rating, and 2 have given a buy rating for PATH.

Consensus Price Target

$17.50
32.08% Upside
According to the 19 analysts' twelve-month price targets for UiPath, the average price target is $17.50. The highest price target for PATH is $30.00, while the lowest price target for PATH is $12.00. The average price target represents a forecasted upside of 32.08% from the current price of $13.25.
Get the Latest News and Ratings for PATH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UiPath and its competitors.

Sign Up

PATH Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
5 Buy rating(s)
Hold
16 Hold rating(s)
16 Hold rating(s)
16 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$17.50$17.47$17.71$21.96
Forecasted Upside32.08% Upside22.60% Upside37.15% Upside-13.56% Downside
Consensus Rating
Hold
Hold
Hold
Hold

PATH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PATH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

UiPath Stock vs. The Competition

TypeUiPathBusiness Services CompaniesS&P 500
Consensus Rating Score
2.05
2.69
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside32.08% Upside169.91% Upside14.52% Upside
News Sentiment Rating
Positive News

See Recent PATH News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/19/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingHold ➝ Hold
12/12/2024UBS Group
4 of 5 stars
J. Hickey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSell$14.00-1.69%
12/6/2024Barclays
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$15.00 ➝ $16.00+9.29%
12/6/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$15.00 ➝ $16.00+8.84%
12/6/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$15.00 ➝ $16.00+9.74%
12/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$16.00 ➝ $16.00+11.50%
12/6/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$17.00 ➝ $18.00+25.44%
10/23/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$15.00 ➝ $13.00+7.44%
9/6/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$17.00 ➝ $16.00+32.34%
9/6/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$13.00 ➝ $15.00+24.07%
9/6/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$13.00 ➝ $16.00+25.59%
9/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$16.00 ➝ $18.00+41.29%
6/3/2024Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
F. Havemeyer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$29.00 ➝ $12.00-2.12%
5/31/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$30.00 ➝ $19.00+57.42%
5/30/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$25.00 ➝ $14.00-23.46%
5/30/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Roberge
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
5/30/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Sector Weight
5/30/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Tillman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$32.00 ➝ $14.00-23.46%
5/29/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ Sector Perform$30.00 ➝ $25.00+36.17%
3/17/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$27.50+61.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 03:48 AM ET.


PATH Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for UiPath is $17.50, with a high forecast of $30.00 and a low forecast of $12.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last year. There is currently 1 sell rating, 16 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.

According to analysts, UiPath's stock has a predicted upside of 32.08% based on their 12-month stock forecasts.

Analysts like UiPath less than other "business services" companies. The consensus rating for UiPath is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how PATH compares to other companies.


This page (NYSE:PATH) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners